Eloxx Pharmaceuticals Inc (OTCPK:ELOX)
$ 0.68557 -0.05443 (-7.36%) Market Cap: 2.15 Mil Enterprise Value: 3.31 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Eloxx Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 22, 2023 / 04:00PM GMT
Release Date Price: $4.15 (-6.32%)
Sumit Aggarwal
Eloxx Pharmaceuticals, Inc. - President & CEO

Good morning. I am Sumit Aggarwal, President, Chief Executive Officer, and Director of Eloxx Pharmaceuticals, Inc., and the Chairperson of today's meeting. I'm very happy to welcome you to our 2023 Annual Meeting of Shareholders. On behalf of Eloxx, the members of the Board, and company management, I hope everyone is safe and healthy.

Also participating today is [Tom McGauley], Controller of the company. We are also joined today by Kristin Godsoe of Baker Tilly, the company's independent registered public accounting firm, who is available to respond to relevant questions raised during the meeting.

Before I call the meeting to order, I'd like to introduce the other Board members of Eloxx: Tomer Kariv, Chairman of the Board, Lindsay Androski, Steven Rubin, and Alan Walts.

The meeting has now officially come to order. We will proceed with the formal business of the meeting as set forth in the notice of the annual meeting and proxy statement. The time is 12:01 PM Eastern Time, and the polls are now open for voting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot